Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Your Laugh of the day

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Aug 17, 2023 10:11am

186 Views

Post# 35592746

RE:RE:Your Laugh of the day

We survived the last time the company was in a tight financial situation, so this is a strong marriage and can easily handle the current issues - but it would help if Trogarzon would emote a little less frequently! As we age, the capacity to tolerate all the angst diminishes!

Lee430 wrote: It just dawned on me that some of us on this message board have been hanging out here waaasay longer than the average marriage last.

Kd5513 wrote:
https://www.cerclecanadien-montreal.ca/en/biography-paul-levesque

Enviable and track record LOL